110 results
Page 3 of 6
6-K
EX-99.1
q2j6gnw31cpu
21 Nov 16
Current report (foreign)
12:00am
20-F/A
EX-4.40
adltnz8dezo
31 May 16
Annual report (foreign) (amended)
12:00am
20-F/A
EX-4.39
btbz 4mfmqf
22 Sep 15
Annual report (foreign) (amended)
12:00am
20-F/A
EX-4.39
4r3gdhbq2q9c
23 Mar 15
Annual report (foreign) (amended)
12:00am
20-F/A
do1tie a6zjcap2b2b
23 Mar 15
Annual report (foreign) (amended)
12:00am
20-F/A
EX-4.38
1bbnjb6e
23 Mar 15
Annual report (foreign) (amended)
12:00am
424B5
fik62f2 21
6 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99
nnk50cx5 7vefll9z3qq
6 Mar 15
BioLineRx Prices $25 Million Underwritten Public Offering
12:00am
6-K
EX-99.2
c5ibtw3tr0htf24c
5 Mar 15
Current report (foreign)
12:00am
424B5
zro5w
5 Mar 15
Prospectus supplement for primary offering
12:00am